Bio-Rad Laboratories, Inc. (Bio-Rad) is a global leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 8,200 employees and $2.8 billion in revenues in 2022. The company’s customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, they develop innovative, high-quality products that advance science and save lives.
Zyme has been working with Bio-Rad since 2018, providing comprehensive PR support to raise awareness of the Company and its life science research products.
As an additional project, Bio-Rad requested Zyme’s support for development and drafting of a series of articles, as part of Bio-Rad’s ‘Antibody Therapeutics’ content track.
The project aimed to create content that connects with the target audiences on their research goals, pain points and / or trends across downstream purification and drug discovery, and to raise awareness of how Bio-Rad supports these specific areas.
Our approach to the content development project included:
- Management of project timelines to ensure delivery of drafts, review rounds, and final versions to meet deadlines
- Advising on article direction and content to align with briefs and client expectations
- Interviewing Bio-Rad SMEs to obtain thought-leadership commentary, to supplement company materials
- Researching, drafting, and editing articles:
- Incorporating relevant peer-reviewed publications, case studies, applications notes, and testimonials, as appropriate
- Tailoring the tone, style and structure to engage the target audiences, specific to each article
- Drafting email copy to accompany each article, for use as part of Bio-Rad marketing campaigns
- Suggesting relevant images and figures to enhance the articles
Deliverables for the project included:
- High quality and engaging articles:
- Four articles covering strategies for the optimal purification of monoclonal antibodies using Bio-Rad’s resins
- One article covering major focus areas and modalities of biopharmaceutical therapies
- Two articles covering immunogenicity and pharmacokinetic assays for antibody drug monitoring and bioanalysis
- Two articles covering regulatory guidelines and safety considerations relevant to therapeutic antibody development
- Concise advertising email copy drafted to promote each article
We have been working with Zyme for over 5 years. The Zyme team is always able to provide us with high quality content on time to meet our needs. The team is great to work with and has a very collaborative approach to ensure that our specific requirements are met or exceeded.
Laura Moriarty, Associate Director, Bio-Rad